Summary Stage 2018: Thyroid

Summary Stage 2018

Notes

**Thyroid** 8000-8700, 8720-8790, 8940-8960, 8965-8983, 9000, 9050-9111, 9270, 9300-9312, 9340-9363, 9380-9539, 9541 C739: Thyroid gland **Note 1:** **Sources used in the development of this chapter** * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 73 *Thyroid-Differentiated and Anaplastic Carcinoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. * Chapter 74 *Thyroid-Medullary*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** **Other Summary Stage Chapters with Thyroid sites** * **GIST**: 8935-8936 * **Kaposi Sarcoma**: 9140 * **Mycosis Fungoides**: 9700-9701 * **Soft Tissue**: 8710-8714, 8800-8934, 8963-8964, 8990-8992, 9010-9045, 9120-9138, 9141-9262, 9271-9290, 9320-9330, 9364-9373, 9540, 9542-9582: **Note 3:** **Psammoma bodies** * Psammoma bodies are counted as positive regional lymph nodes

NAACCR Item

NAACCR #764
SS2018 Description
0 **In situ: noninvasive, intraepithelial**
1 **Localized only (localized, NOS)** * Confined to thyroid, NOS * Into thyroid capsule, but not beyond * Multiple foci confined to thyroid * Single invasive tumor confined to thyroid
2 **Regional by direct extension only** * Blood vessel(s) (major) - Carotid artery (encased) - Jugular vein - Thyroid artery or vein * Cricoid cartilage * Esophagus * Extrathyroidal extension (microscopic, macroscopic, NOS) * Larynx * Nerves - Recurrent laryngeal - Vagus nerve * Parathyroid * Pericapsular soft tissue/connective tissue * Sternocleidomastoid muscle * Strap muscle(s) - Omohyoid - Sternohyoid - Sternothyroid - Thyrohyoid * Subcutaneous soft tissue * Thyroid cartilage * Trachea * Tumor described as "FIXED to adjacent tissues"
3 **Regional lymph node(s) involved only** * Level I - Level IA - Submental - Level IB - Submandibular * Level II - Upper jugular - Jugulodigastric (subdigastric) - Upper deep cervical - Level IIA - Anterior - Level IIB - Posterior * Level III - Middle jugular - Middle deep cervical * Level IV - Lower jugular - Jugulo-omohyoid (supraomohyoid) - Lower deep cervical - Virchow node * Level V - Posterior triangle group - Posterior cervical - Level VA - Spinal accessory - Level VB - Transverse cervical, supraclavicular * Level VI - Anterior compartment group - Laterotracheal - Paralaryngeal - Paratracheal - above suprasternal notch - Perithyroidal - Precricoid (Delphian) - Prelaryngeal - Pretracheal - above suprasternal notch - Recurrent laryngeal * Level VII - Superior mediastinal group (for other mediastinal node(s) see code 7) - Esophageal groove - Paratracheal - below suprasternal notch - Pretracheal - below suprasternal notch * Other lymph nodes - Cervical, NOS - Deep cervical, NOS - Facial + Buccinator (buccal) + Mandibular + Nasolabial - Internal jugular, NOS - Parapharyngeal - Parotid + Infraauricular + Intraparotid + Periparotid + Preauricular - Retroauricular (mastoid) - Retropharyngeal - Suboccipital * Regional lymph node(s), NOS - Lymph node(s), NOS
4 **Regional by BOTH direct extension AND regional lymph node(s) involved** * Codes (2) + (3)
7 **Distant site(s)/lymph node(s) involved** * Distant site(s) (including further contiguous extension) - Gross extrathyroidal extension invading + Bone + Mediastinal tissues + Prevertebral fascia + Skeletal muscle, other than strap or sternocleidomastoid muscle * Distant lymph node(s), NOS * Distant metastasis, NOS - Carcinomatosis - Distant mets WITH or WITHOUT distant lymph node(s)
9 Unknown if extension or metastasis
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017 (5) Tuttle, R.M., Perrier, N.D., et al. **Thyroid - Differentiated and Anaplastic Carcinoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017 (6) Rosen, J.E., Lloyd, R.V., Perrier, N.D., et al. **Thyroid - Medullary**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017